Press Releases Year All202420232022 04/23/24 Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution 04/16/24 Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024 04/02/24 Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart 02/28/24 Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution 02/21/24 Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024 01/04/24 Kiniksa Pharmaceuticals Provides Corporate Update 01/02/24 Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference Print Page RSS Email Alerts Search
Year All202420232022 04/23/24 Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution 04/16/24 Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024 04/02/24 Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart 02/28/24 Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution 02/21/24 Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024 01/04/24 Kiniksa Pharmaceuticals Provides Corporate Update 01/02/24 Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference